Tomocube

토모큐브 · 475960

Information Technology Components · KOSDAQ

Small-cap

Market cap US$395.7M (₩546B)

Overview

Tomocube makes advanced cell-imaging instruments that let researchers and clinicians examine living cells in three dimensions without staining or labeling them, using a technology called holotomography.

Its instruments are used in biomedical research and diagnostics. Listed on KOSDAQ, Korea's tech-focused small-cap exchange, the company earns the large majority of its revenue from its holotomography instrument line, with consumables and services making up only a small share. Most of its revenue comes from overseas markets rather than domestic Korean sales.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025
Revenue · FY2025
US$8.2M
▲ +90.4% YoY
Operating profit · FY2025
−US$4M
Loss narrowed
Net income · FY2025
−US$3.5M
Loss narrowed

Revenue

  • FY2024US$4.3M
  • FY2025US$8.2M

Operating profit

  • FY2024−US$6.4M
  • FY2025−US$4M

Net income

  • FY2024−US$6M
  • FY2025−US$3.5M

Key ratios (FY2025)

ROE
-12.4%
Debt/Eq
7.0%
Op. margin
-49.3%
Net margin
-42.5%
Rev. YoY
▲ +90.4%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-06-12 (KST). · FX: 1 USD ≈ ₩1,380 (2026-06-01).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.